Current Trends and New Evidence in Approaches NAS Treatment
Tuesday • April 18, 2023
7:30 AM
- 8:30 AM
This ECHO is exclusively for birthing hospital teams.
Neonatal abstinence syndrome (NAS) is a clinical diagnosis and a consequence of the abrupt discontinuation of chronic fetal exposure to substances that were used or abused by mothers during pregnancy. Between 2010 and 2017, the rate of NAS increased nationally. Over 20,000 babies are born each year in the United States dependent on illegal or prescription drugs and suffer Neonatal Abstinence Syndrome.
Birthing hospital practice standards for NAS/SEI family-centered care can influence this growing statistic, improve the neonatal hospital stay, and ensure a successful transition of mother and infant from hospital to home.
Learn how to implement best practices, alternative recovery interventions, and to support family formation by using plans of safe care and community resources. Experts in medical and social science will lead a dialogue and working sessions with your peers where you will discuss birthing hospital best practices and current quality improvement implementation. Together we can insure an optimal transition from hospital to home to ensure a safe and healthy first year for infants and their families.
No information available at this time
Information regarding the increase in neonatal abstinence syndrome obtained from Cureus, to read more, click here.
Information regarding the number of infants born in the United States with neonatal abstinence syndrome obtained from National Institute for Children’s Health Quality, to read more, click here.
© 2022 All rights reserved
Rutgers Project ECHO is administered by Rutgers Robert Wood Johnson Medical School with generous support from NJ Department of Health, NJ Department Human Services, and other funders.